![](/images/graphics-bg.png)
EGFR Signaling in Colorectal Carcinoma
Author
Source
Pathology Research International
Issue
Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-6, 6 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-02-14
Country of Publication
Egypt
No. of Pages
6
Main Subjects
Abstract EN
The epidermal growth factor receptor (EGFR) and its downstream signaling pathways are involved in the development and progression of several human tumors, including colorectal cancer.
Much attention has been given to the EGFR pathway as of lately because both EGFR and some downstream components serve as targets for anticancer therapy.
In addition to playing a critical role in targeted therapy, alterations in this pathway can have prognostic implications.
The EGFR pathway and its impact on colorectal carcinogenesis and prognosis are the emphasis of this paper.
Since prognosis is tightly related to response to various therapies, the predictive value of the components of this pathway will be briefly discussed, but this is not the focus of this paper.
American Psychological Association (APA)
Krasinskas, Alyssa M.. 2011. EGFR Signaling in Colorectal Carcinoma. Pathology Research International،Vol. 2011, no. 2011, pp.1-6.
https://search.emarefa.net/detail/BIM-509333
Modern Language Association (MLA)
Krasinskas, Alyssa M.. EGFR Signaling in Colorectal Carcinoma. Pathology Research International No. 2011 (2011), pp.1-6.
https://search.emarefa.net/detail/BIM-509333
American Medical Association (AMA)
Krasinskas, Alyssa M.. EGFR Signaling in Colorectal Carcinoma. Pathology Research International. 2011. Vol. 2011, no. 2011, pp.1-6.
https://search.emarefa.net/detail/BIM-509333
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-509333